dockets: FDA-2013-N-1676

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2013-N-1676 FDA International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Tapentadol; N-benzylpiperazine (BZP); gamma-Butyrolactone (GBL); 1,4-Butanediol (I,4 BD); (1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-018); (1-butyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-073); [1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone; Request for Comments Nonrulemaking 2018-04-09T14:41:14Z 0b000064814d3840         ["cder", "cder2013255", "open"] CDER International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs     {"displayProperties": [{"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["cder", "cder2013255", "open"], "modifyDate": "2018-04-09T14:41:14Z", "dkAbstract": null, "agencyId": "FDA", "program": "CDER", "shortTitle": "International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs", "subType2": null, "title": "International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Tapentadol; N-benzylpiperazine (BZP); gamma-Butyrolactone (GBL); 1,4-Butanediol (I,4 BD); (1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-018); (1-butyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-073); [1-(5-fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone; Request for Comments", "generic": "N", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "OPEN", "effectiveDate": null, "objectId": "0b000064814d3840"} single_get

Links from other tables